相关实验视频

Updated: Jan 15, 2026

Synthesis and Performance Evaluations of ZnCoS/ZnCdS with Twin Crystal Structure for Multifunctional Redox Photocatalysis in Energy Applications

Synthesis and Performance Evaluations of ZnCoS/ZnCdS with Twin Crystal Structure for Multifunctional Redox Photocatalysis in Energy Applications

Published on: July 25, 2025

多功能RuO₂ 敏感化Co₃O₄ 核心外索诺酶异构连接用于声动力学和纳米催化协同放大免疫疗法

Guijun Zou^1,2, Nan Wang³, Rui Ma²

¹Department of General Surgery, the First Medical Center, Chinese PLA General Hospital, Beijing, 100853, China.

Small (Weinheim an der Bergstrasse, Germany)

|October 14, 2025

概括

这项研究引入了新的Co3O4@RuO2异构结索诺酶,可以增强癌症免疫疗法. 这些纳米酶有效地促进反应性氧物种 (ROS) 的产生,触发免疫细胞死亡 (ICD) 和强大的抗瘤免疫反应.

科学领域:

生物医学工程生物医学工程
纳米技术纳米技术
癌症研究癌症研究

背景情况:

反应性氧物种 (ROS) 介导的免疫性细胞死亡 (ICD) 对抗瘤免疫非常重要.
声动力学和纳米催化疗法 (SDT/NCT) 是有前途的,但受到低ROS生成和免疫抑制瘤微环境 (TME) 的限制.

研究的目的:

开发一种新的异质连接纳米平台,用于增强SDT/NCT和癌症免疫治疗.
为了研究Co3O4@RuO2异构结索诺酶在克服TME限制方面的协同效应.

主要方法:

核心外Co3O4@RuO2异质连接索诺酶的构造.
评估增强的声动力学和多酶仿真活动.
评估ROS生成,ICD诱导和抗瘤免疫反应放大.

主要成果:

Co3O4@RuO2异质结索诺酶表现出更好的电子孔分离动力学,从而提高了催化活性.
纳米平台通过耗尽GSH和缓解缺氧,有效地增加了ROS产量,诱导了强大的ICD效应.
Co3O4@RuO2介导的SDT/NCT显著消除了初级瘤,并通过放大免疫疗法抑制了远程瘤生长.

结论:

在Co3O4@RuO2sonozymes中,异构连接的构建为增强抗瘤免疫反应提供了一个有前途的策略.
这种新型纳米平台有效地克服了与TME相关的局限性,证明了癌症治疗的重大治疗潜力.
这项研究为开发先进的纳米药物提供了有价值的见解,以获得持久和强大的抗癌免疫力.

关键词:

有关CO3O4的研究.二氧化 (RuO2) 是一种有机物.异质连接的 sonozymes 是一种酶.免疫疗法免疫疗法声动力学疗法声动力学疗法

更多相关视频

Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy

Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy

Published on: May 22, 2020

Developing Photosensitizer-Cobaloxime Hybrids for Solar-Driven H2 Production in Aqueous Aerobic Conditions

Developing Photosensitizer-Cobaloxime Hybrids for Solar-Driven H2 Production in Aqueous Aerobic Conditions

Published on: October 5, 2019

相关概念视频

Ribozymes

Ribozymes

Ribozymes

Ribozymes

The term ribozyme is used for RNA that can act as an enzyme. Ribozymes are mainly found in selected viruses, bacteria, plant organelles, and lower eukaryotes. Ribozymes were first discovered in 1982 when Tom Cech’s laboratory observed Group I introns acting as enzymes. This was shortly followed by the discovery of another ribozyme, Ribonulcease P, by Sid Altman’s laboratory. Both Cech and Altman received the Nobel Prize in chemistry in 1989 for their work on ribozymes.
Ribozymes can...

Transducer Mechanism: Enzyme-Linked Receptors

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.